38
Participants
Start Date
December 22, 2019
Primary Completion Date
April 16, 2020
Study Completion Date
April 16, 2020
ACH-0145228
ACH-0145228 was dosed as 2 x 60 milligram (mg) (Part 1) or 1 x 40 mg (Part 2) powder in capsules.
Midazolam
Midazolam was dosed at 2 mg (1 milliliter \[mL\] of a 2 mg/mL syrup).
Digoxin
Digoxin was dosed as Lanoxin (or generic equivalent) at 1 x 0.25 mg tablet.
Itraconazole
Itraconazole was dosed as Sporanox (or generic equivalent) at 200 mg (20 mL of a 10 mg/mL oral solution).
Clinical Study Site, Tempe
Lead Sponsor
Collaborators (1)
Achillion, a wholly owned subsidiary of Alexion
INDUSTRY
Celerion
INDUSTRY
Alexion Pharmaceuticals, Inc.
INDUSTRY